1. Home
  2. Products
  3. Functional Peptides
  4. Targeting Peptides

Targeting Peptides

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
Name CAS MF MW Single-letter sequence Three-letter sequence Number of AA Type Inquiry
SP5.2 C96H123N21O27S1 2035.19 H2N–NGYEIEWYSWVTHGMY–OH H2N–Asn–Gly–Tyr–Glu–Ile–Glu–Trp–Tyr–Ser–Trp–Val–Thr–His–Gly–Met–Tyr–OH 16 VEGFR1 (Flt-1)–targeting peptide
RMWPSSTVNLSAGRR C72H120N26O21S1 1717.95 H2N–RMWPSSTVNLSAGRR–OH H2N–Arg–Met–Trp–Pro–Ser–Ser–Thr–Val–Asn–Leu–Ser–Ala–Gly–Arg–Arg–OH 15 CD21-targeting peptide
LMNPNNHPRTPR C60H99N23O17S1 1446.64 H2N–LMNPNNHPRTPR–OH H2N–Leu–Met–Asn–Pro–Asn–Asn–His–Pro–Arg–Thr–Pro–Arg–OH 12 PKCδ-targeting peptide
ANLNLWTDYIRW C74H105N19O19 1564.74 H2N–ANLNLWTDYIRW–OH H2N–Ala–Asn–Leu–Asn–Leu–Trp–Thr–Asp–Tyr–Ile–Arg–Trp–OH 12 Colon cancer–targeting peptide
PTPRJ-pep19 C41H60N16O12S2 1033.15 H₂N-CHHNLTHAC-OH H₂N-Cys-His-His-Asn-Leu-Thr-His-Ala-Cys-OH 9 PTPRJ-targeting peptide
PTPRJ-pep24 C44H59N15O12S2 1054.16 H₂N-CLHHYHGSC-OH H₂N-Cys-Leu-His-His-Tyr-His-Gly-Ser-Cys-OH 9 PTPRJ-targeting peptide
PTPRJ-19.4 C40H59N15O11S2 990.12 H₂N-CHHALTHAC-OH H₂N-Cys-His-His-Ala-Leu-Thr-His-Ala-Cys-OH 9 PTPRJ-targeting peptide
TJ12P1 C67H94N16O19 1427.56 H2N-DHLASLWWGTEL-OH H2N-Asp-His-Leu-Ala-Ser-Leu-Trp-Trp-Gly-Thr-Glu-Leu-OH 12 GPC3-targeting peptide
Nelipepimut-S 160212-35-1 C50H78N10O11 995.21 H2N-KIFGSLAFL-OH H2N-Lys-Ile-Phe-Gly-Ser-Leu-Ala-Phe-Leu-OH 9 HER2-targeting peptide
CM7 C32H54N10O13 786.83 H2N-DQIIANN-OH H2N-Asp-Gln-Ile-Ile-Ala-Asn-Asn-OH 7 c-Met–targeting peptide
C25 C43H68N12O12S3 1041.27 H2N-CVPMTYRAC-OH H2N-Cys-Val-Pro-Met-Thr-Tyr-Arg-Ala-Cys-OH 9 LAG-3–targeting peptide
P26 C58H101N15O15S1 1280.58 H2N-GLIPLTTMHIGK-OH H2N-Gly-Leu-Ile-Pro-Leu-Thr-Thr-Met-His-Ile-Gly-Lys-OH 12 TIM-3–targeting peptide
TPP-1 C84H111N25O22S2 1887.06 H2N-YASYHCWCWRDPGRS-OH H2N-Tyr-Ala-Ser-Tyr-His-Cys-Trp-Cys-Trp-Arg-Asp-Pro-Gly-Arg-Ser-OH 15 PD-L1–targeting peptide
YT-16 C80H120N20O24S3 1842.12 H2N-YRCMISYGGADYKCIT-OH H2N-Tyr-Arg-Cys-Met-Ile-Ser-Tyr-Gly-Gly-Ala-Asp-Tyr-Lys-Cys-Ile-Thr-OH 16 PD-1–targeting peptide
TJ12P2 C60H104N22O19 1437.6 H2N–SNDRPPNILQKR–OH H2N–Ser–Asn–Asp–Arg–Pro–Pro–Asn–Ile–Leu–Gln–Lys–Arg–OH 12 GPC3-targeting peptide
CNLNTIDTC C38H65N11O16S2 996.12 H2N-CNLNTIDTC-OH H2N-Cys-Asn-Leu-Asn-Thr-Ile-Asp-Thr-Cys-OH 9 CD44v6-binding peptide
CNEWQLKSC C46H71N13O15S2 1110.26 H2N-CNEWQLKSC-OH H2N-Cys-Asn-Glu-Trp-Gln-Leu-Lys-Ser-Cys-OH 9 CD44v6-binding peptide
SMSIARL C32H60N10O10S1 776.94 H2N-SMSIARL-OH H2N-Ser-Met-Ser-Ile-Ala-Arg-Leu-OH 7 Prostate tumor–targeting peptide
CSNRDARRC C38H69N19O14S2 1080.2 H2N-CSNRDARRC-OH H2N-Cys-Ser-Asn-Arg-Asp-Ala-Arg-Arg-Cys-OH 9 Bladder tumor–targeting peptide
KTVRTSADE C40H71N13O17 1006.07 H2N-KTVRTSADE-OH H2N-Lys-Thr-Val-Arg-Thr-Ser-Ala-Asp-Glu-OH 9 EDB-FN–targeting peptide